Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-Study.

导出 OA

翻译打印收藏纠错

第一作者： Roland E,Schmieder

第一单位： Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich Alexander University Erlangen Nürnberg, Germany (R.E.S.).

作者： Roland E,Schmieder ^[1] ; Sven,Wassmann ^[2] ; Hans-Georg,Predel ^[3] ; Burkhard,Weisser ^[4] ; Jörg,Blettenberg ^[5] ; Anton,Gillessen ^[6] ; Olaf,Randerath ^[7] ; Antje,Mevius ^[8] ; Thomas,Wilke ^[8] ; Michael,Böhm ^[9]

作者单位： Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich Alexander University Erlangen Nürnberg, Germany (R.E.S.). ^[1] Cardiology Pasing, Faculty of Medicine, Munich and University of the Saarland, Homburg/Saar, Germany (S.W.). ^[2] Institute of Cardiology and Sports Medicine, German Sport University, Cologne, Germany (H.-G.P.). ^[3] Institute of Sports Science, Christian-Albrechts-Universität zu Kiel, Germany (B.W.). ^[4] Practice Dr. J. Blettenberg, Lindlar, Germany (J.B.). ^[5] Herz-Jesu-Hospital, Department of Internal Medicine, Münster (A.G.). ^[6] Medical Department, APONTIS PHARMA Deutschland GmbH & Co. KG, Monheim, Germany (O.R.). ^[7] Institut für Pharmakoökonomie und Arzneimittellogistik (IPAM), Wismar, Germany (A.M., T.W.). ^[8] Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Saarland University, Homburg/Saar, Germany (M.B.). ^[9]

关键词 antihypertensive agents cardiovascular diseases hypertension medication adherence mortality prognosis risk factors